With continued investment in mRNA research, Donald Trump could turn the stalemate against cancer into a decisive breakthrough ...

Researchers showed that an mRNA influenza vaccine delivered with their new lipid nanoparticle could generate the same immune ...

According to Nova One Advisor, the global mRNA synthesis & manufacturing market size is calculated at USD 1.58 billion in 2025 and is expected to be hit around USD 1.87 billion by 2034, growing at a ...

India's Coronavirus Vaccine Market offers growth through government-led initiatives, robust manufacturing, and R&D in vaccine ...

A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine ...

Research reveals mRNA COVID-19 vaccines may enhance cancer immunotherapy effectiveness, extending survival for lung and skin ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

The decline follows a $500m cut in grant support by the US HHS. Venture financing for mRNA-based innovator vaccines declined ...

Australia's Victoria state on Wednesday unveiled plans to develop an onshore messenger-RNA (mRNA) vaccine manufacturing facility and launched three mass coronavirus immunisation centres to speed up ...

Investigators from the University of Science and Technology of China and RNAlfa Biotech have described a novel mRNA-based vaccine candidate against Dabie Banda virus (DBV), which has fatality rates of ...